What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?

Biologic therapies have revolutionised disease control in patients with rheumatoid arthritis (RA). Theoretically, they have the potential to influence co-morbid disease associated with RA through better control of systemic inflammation. Conversely, co-morbidity may occur as an adverse effect of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphreys, Jenny, Hyrich, Kimme, Symmons, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134078/
https://www.ncbi.nlm.nih.gov/pubmed/27906042
http://dx.doi.org/10.1186/s13075-016-1176-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134078/
https://www.ncbi.nlm.nih.gov/pubmed/27906042
http://dx.doi.org/10.1186/s13075-016-1176-x

Ejemplares similares